Beyond Medicine, a digital therapeutics company (CEO Daehyun Kim) , announced that it will participate in 'Japan IT Week Autumn 2025' held in Tokyo, Japan from October 22nd to 24th and introduce 'Clickless', a solution for improving temporomandibular joint disorder.
Japan IT Week Autumn is Japan's largest information technology exhibition, encompassing cutting-edge industries such as AI, cloud computing, security, and software. This year, approximately 700 companies and 30,000 industry professionals will participate, establishing the event as a platform for global technological collaboration and partnership building beyond technology exhibitions.
Through this exhibition, Beyond Medicine will explore partnerships for entry into the Japanese digital healthcare market and introduce its flagship product, Clickless, a digital treatment for temporomandibular joint disorder.
Clickless is a digital treatment solution based on cognitive behavioral therapy (CBT) designed to help patients with temporomandibular joint disorder (TMJ) correct their lifestyle habits and manage their condition through self-management. It operates using only a smartphone camera, eliminating the need for separate wearable devices. Patients can continue the treatment process as they normally would, while medical staff can review treatment data in real time through a cloud-based platform and propose customized treatment plans.
The product's main functions include ▲improvement of lifestyle habits ▲cognitive behavioral therapy based on pain records ▲self-rehabilitation exercise program ▲meditation therapy, etc., and it consists of a non-drug-based treatment program that lasts 10 minutes a day for 6 weeks.
Beyond Medicine plans to use this exhibition as a springboard to concretize its Japanese market entry strategy and pursue the establishment of a local subsidiary. The company plans to launch its digital therapeutics business in earnest by establishing a foundation for collaboration with medical institutions and completing regulatory approvals in Japan.
CEO Kim Dae-hyun stated, “Through this exhibition, we plan to strengthen cooperation with local digital healthcare partners in Japan and refine our market entry strategy. Based on our localization strategy, we will grow into a company that provides competitive solutions in the global digital therapeutics market.”
- See more related articles
You must be logged in to post a comment.